Table 1.

Cross-sectional studies of spine bone mineral density in children on glucocorticoid therapy

References	Condition, sample size	Glucocorticoid dose and duration	Quality score
Falcini et al. [16]	JIA cases, n = 16	Deflazacort median 0.8 mg/kg/day	15/21
	JIA controls, n = 24	0.3–2.0 mg/kg/day
	Healthy controls, n = 40	Range: 6 months to 3 years
Celiker et al. [20]	JIA cases, n = 17	Prednisolone	14/20
	JIA controls, n = 11	≥ 7.5 mg/day
	Healthy controls, n = 45	≥ 5 months
Brik et al. [19]	JIA cases, n = 10	Prednisone	16/21
	JIA controls, n = 7	0.4 mg ± 0.2 mg/kg/day
	Healthy controls, n = 18	2.5 ± 1.3 years
Kashef et al. [21]	JIA or SLE cases, n = 20	GC not specified	17/21
	Healthy controls, n = 20	6.6 ± 3.2 mg/day
		≥ 6 months

JIA = juvenile inflammatory arthritis; SLE = systemic lupus erythematosus; GC = glucocorticoid therapy.